Clinical aspects and outcome of suspected severe pediatric malaria

J Losimba Likwela1, U D'Alessandro, P Donnen

  • 1Faculté de médecine, université de Kisangani, BP 2012, Kisangani, Democratic Republic of Congo. drjoris@yahoo.fr

Insights

Diagnosis and treatment of severe malaria in children in Kisangani revealed high fatality rates, particularly when diagnostic tests were not performed. Inadequate hospital support hinders effective management of severe childhood infections.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Severe malaria remains a significant cause of childhood mortality in endemic regions.
  • Accurate diagnosis and timely treatment are critical for improving outcomes in pediatric severe malaria cases.

Purpose of the Study:

  • To evaluate the diagnostic and treatment practices for children with clinically suspected severe malaria.
  • To assess the impact of diagnostic methods and hospital organization on patient outcomes in Kisangani.

Main Methods:

  • A prospective study was conducted in two referral hospitals in Kisangani from January 2010 to February 2011.
  • Included children admitted with clinically suspected severe malaria and at least one WHO severity criterion.
  • Diagnostic confirmation relied on thick drop examination (TDE), with data on treatment and outcomes collected.

Main Results:

  • Of 427 children with suspected severe malaria, 37.0% had positive TDE, 46.4% negative, and 17.3% lacked TDE.
  • Prostration (48.0%) and anemia (40.3%) were the most frequent severity criteria.
  • The overall case fatality rate was 19.4%, significantly higher in patients without TDE (70.3%) compared to confirmed cases (7.7%) (P <0.001).

Conclusions:

  • Inadequate technical support and patient management systems can lead to underestimation of severe malaria complications.
  • Effective antimalarial drugs are insufficient if diagnostic and organizational challenges persist.
  • Improving diagnostic capacity and hospital infrastructure is crucial for reducing severe malaria mortality in children.
Abstract

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...